CDKN2A and Mental deterioration: The cyclin-dependent kinase inhibitor p16INK4a (encoded by CDKN2A), a key regulator of cellular senescence, has been identified as a highly specific biomarker of aging-related cognitive decline in both animal models and human postmortem studies11,12.